Literature DB >> 19669783

Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development.

Susan M Smith1, John M Whitelock, Renato V Iozzo, Christopher B Little, James Melrose.   

Abstract

We evaluated the immunohistochemical distribution of three major proteoglycans of cartilage, i.e., aggrecan, versican and perlecan vis-a-vis collagens I and II in the developing human spine of first-trimester foetuses. Aggrecan and perlecan were prominently immunolocalised in the cartilaginous vertebral body rudiments and to a lesser extent within the foetal intervertebral disc. In contrast, versican was only expressed in the developing intervertebral disc interspace. Using domain-specific monoclonal antibodies against the various modules of versican, we discovered the V0 isoform as the predominant form present. Versican immunolocalisations conducted with antibodies directed to epitopes in its N and C termini and GAG-alpha and GAG-beta core protein domains provided evidence that versican in the nucleus pulposus was either synthesised devoid of a G3 domain or this domain was proteolytically removed in situ. The V0 versican isoform was localised with prominent fibrillar components in the annular lamellae of the outer annulus fibrosus. Perlecan was a notable pericellular proteoglycan in the annulus fibrosus and nucleus pulposus but poorly immunolocalised in the marginal tissues of the developing intervertebral disc, apparently delineating the intervertebral disc-vertebral body interface region destined to become the cartilaginous endplate in the mature intervertebral disc. The distribution of collagens I and II in the foetal spine was mutually exclusive with type I present in the outer annulus fibrosus, marginal tissues around the vertebral body rudiment and throughout the developing intervertebral disc, and type II prominent in the vertebral rudiment, absent in the outer annulus fibrosus and diffusely distributed in the inner annulus fibrosus and nucleus pulposus. Collectively, our findings suggest the existence of an intricate and finely balanced interplay between various proteoglycans and collagens and the spinal cell populations which synthesise and assemble these components during spinal development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19669783     DOI: 10.1007/s00418-009-0623-z

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  72 in total

1.  Extracellular matrix in development of the intervertebral disc.

Authors:  A J Hayes; M Benjamin; J R Ralphs
Journal:  Matrix Biol       Date:  2001-04       Impact factor: 11.583

Review 2.  Basement membrane proteoglycans: from cellar to ceiling.

Authors:  Renato V Iozzo
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

3.  Immunolocalization of major interstitial collagen types in human lumbar intervertebral discs of various ages.

Authors:  A G Nerlich; N Boos; I Wiest; M Aebi
Journal:  Virchows Arch       Date:  1998-01       Impact factor: 4.064

4.  X-ray diffraction studies of the arrangement of collagenous fibres in human fetal intervertebral disc.

Authors:  D S Hickey; D W Hukins
Journal:  J Anat       Date:  1980-08       Impact factor: 2.610

5.  Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican.

Authors:  A Aspberg; S Adam; G Kostka; R Timpl; D Heinegård
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

6.  Limb chondrogenesis is compromised in the versican deficient hdf mouse.

Authors:  Dennis R Williams; Ashley R Presar; A Todd Richmond; Corey H Mjaatvedt; Stanley Hoffman; Anthony A Capehart
Journal:  Biochem Biophys Res Commun       Date:  2005-09-02       Impact factor: 3.575

7.  Three-dimensional architecture and development of lumber intervertebral discs.

Authors:  H Hashizume
Journal:  Acta Med Okayama       Date:  1980-11       Impact factor: 0.892

Review 8.  Biological treatment for degenerative disc disease: implications for the field of physical medicine and rehabilitation.

Authors:  Yejia Zhang; Howard S An; Chadi Tannoury; Eugene J-M A Thonar; Mitchell K Freedman; D Greg Anderson
Journal:  Am J Phys Med Rehabil       Date:  2008-09       Impact factor: 2.159

Review 9.  Strategies for regeneration of the intervertebral disc.

Authors:  N S Kalson; S Richardson; J A Hoyland
Journal:  Regen Med       Date:  2008-09       Impact factor: 3.806

10.  Versican expression during synovial joint morphogenesis.

Authors:  John B Shepard; Heidi A Krug; Brooklynn A LaFoon; Stanley Hoffman; Anthony A Capehart
Journal:  Int J Biol Sci       Date:  2007-09-07       Impact factor: 6.580

View more
  18 in total

Review 1.  Proteoglycomics: recent progress and future challenges.

Authors:  Mellisa Ly; Tatiana N Laremore; Robert J Linhardt
Journal:  OMICS       Date:  2010-08

Review 2.  Extending the knowledge in histochemistry and cell biology.

Authors:  Wolfgang-Moritz Heupel; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2009-11-28       Impact factor: 4.304

3.  Proteoglycans in Normal and Healing Skin.

Authors:  Margaret Mary Smith; James Melrose
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

4.  Influence of maturity on nucleus-endplate integration in the ovine lumbar spine.

Authors:  Kelly R Wade; Peter A Robertson; Neil D Broom
Journal:  Eur Spine J       Date:  2014-02-20       Impact factor: 3.134

5.  Comparative immunolocalisation of perlecan with collagen II and aggrecan in human foetal, newborn and adult ovine joint tissues demonstrates perlecan as an early developmental chondrogenic marker.

Authors:  Susan M Smith; Cindy Shu; James Melrose
Journal:  Histochem Cell Biol       Date:  2010-08-06       Impact factor: 4.304

6.  The distribution of fibrillin-2 and LTBP-2, and their co-localisation with fibrillin-1 in adult bovine tail disc.

Authors:  Bing Li; Jill P G Urban; Jing Yu
Journal:  J Anat       Date:  2011-11-20       Impact factor: 2.610

7.  Correlation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative Immunohistochemistry.

Authors:  Jessica M Snyder; Ida M Washington; Timothy Birkland; Mary Y Chang; Charles W Frevert
Journal:  J Histochem Cytochem       Date:  2015-09-18       Impact factor: 2.479

Review 8.  A current view of perlecan in physiology and pathology: A mosaic of functions.

Authors:  Maria A Gubbiotti; Thomas Neill; Renato V Iozzo
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

9.  Comparative immunolocalisation of fibrillin-1 and perlecan in the human foetal, and HS-deficient hspg2 exon 3 null mutant mouse intervertebral disc.

Authors:  Anthony J Hayes; Susan M Smith; James Melrose
Journal:  Histochem Cell Biol       Date:  2012-10-27       Impact factor: 4.304

10.  Comparative immunolocalisation of perlecan, heparan sulphate, fibroblast growth factor-18, and fibroblast growth factor receptor-3 and their prospective roles in chondrogenic and osteogenic development of the human foetal spine.

Authors:  Cindy Shu; Susan S Smith; Christopher B Little; James Melrose
Journal:  Eur Spine J       Date:  2013-02-10       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.